Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. - Wikidata - wikimedia - TriplyDB

Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors.

Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors.

http://www.wikidata.org/entity/Q44094350

about

Gene therapy for sickle cell disease Treatment for avascular necrosis of bone in people with sickle cell disease Treatment for avascular necrosis of bone in people with sickle cell disease Gene therapy for sickle cell disease Gene therapy for sickle cell disease Treatment for avascular necrosis of bone in people with sickle cell disease Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease Treatment for avascular necrosis of bone in people with sickle cell disease Online biomedical resources for malaria-related red cell disorders Effects of hydroxyurea treatment for patients with hemoglobin SC disease.Improved survival of children and adolescents with sickle cell disease.Gene therapy for sickle cell disease.Survival of children with sickle cell disease.Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study.N-acetylcysteine reduces oxidative stress in sickle cell patients Hemoglobin sickle cell disease complications: a clinical study of 179 cases Staged single-ventricle palliation in an infant with hemoglobin SC disease.Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.Sickle cell disease in North Europe.Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease Nucleosomes and neutrophil activation in sickle cell disease painful crisis.Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.Knowledge insufficient: the management of haemoglobin SC disease.Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality.Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.Acute chest syndrome is associated with history of asthma in hemoglobin SC disease.The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana

P2860

Q24193117-FE0AC8D0-525A-45BD-A65E-7F39A59F838B Q24194880-7B6CED09-971A-421F-A090-C03487FB5B06 Q24197657-917A50A3-0201-4EED-902B-76D713063F60 Q24202911-0DC7989F-03A4-4E40-AFF2-C12F2EF5EDA0 Q24236524-9650131D-530D-4FF0-B525-B2086C28FAB8 Q24239919-D54A1958-A37D-492A-A7E5-BAB1A7DA6AA8 Q24606163-6A60415A-C05D-4152-BB33-3D6975F58AAE Q26470484-FCD9B631-C3DC-4D90-BD92-4AF89ABA5559 Q27024694-3895C717-E320-47E4-93DA-17229ECACA26 Q33427950-68C3BBC4-3354-4759-AB48-ABF043F196F1 Q33839801-960893F6-8CDC-4E33-96E6-1E26B077DA8D Q34544622-9F17A1B8-96F6-42AB-AFEE-FF888D558C79 Q35690101-5E932491-C4A5-48D3-9749-C84A2405292A Q36005899-77D9C780-0626-4893-B4A6-089DDFFA8A09 Q36010842-BB70E70D-1B99-4C19-8DA0-2F4F0285E843 Q36132987-35954883-A95D-4E13-B136-2E6DF21779A6 Q36319271-25699331-8C69-4EB0-A641-B37AF2E27FB7 Q36543053-05F4DF31-EB06-4051-97DF-7CD23FF17BCB Q36560689-64B034D4-2C91-4B2E-9278-5A46A007F9ED Q36762093-B918B679-7329-425D-8678-D8E141D0BD98 Q37107190-B842714F-9A1A-41F0-8990-BA62150AD531 Q37273218-E0FE1E21-AE22-4CF6-880A-DE058EDF32C1 Q37736976-880A264B-AA4F-4CD9-943D-D3C3C8E0E0C6 Q39041106-27F8AD8B-0CD5-43B7-9CB8-1ECFA2BD4CCA Q40644414-2408E86C-C629-4839-8897-44F9050AAFBC Q41034960-1AE70C0D-6125-43CC-AEB0-55C78FF4A0E2 Q46015716-7CFCDFBA-6A58-403C-8794-ED6835A054D2 Q53674092-BD5BC94B-D338-478A-A4C5-C4820ACA4205 Q55427971-859B1623-77CE-4573-B650-83E8CE53330F Q58761537-FB2B0D3D-DC2E-4B79-B0C5-F02CEA017D82

P2860

Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors.

http://www.wikidata.org/entity/Q44094350

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@en

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@nl

type

label

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@en

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@nl

prefLabel

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@en

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@nl

P1433

Q44094350-B6245F1D-9975-4DDB-B45F-76EA5D1277B1

P1476

Q44094350-BC4E6A5A-2CA8-4E34-859A-B12AE0A1AA56

P2093

Q44094350-2AB7D225-36D9-46CA-9221-659206C27B3F

Q44094350-67959DDA-396E-4ACD-80C8-28E18260E75B

Q44094350-8B21256D-F219-49FA-85ED-317D12816E10

Q44094350-A6BB36C0-1350-4655-BF17-0A63483C3338

Q44094350-BB83936F-4AF6-471E-A500-3F7DA7E21E2A

P2860

Q44094350-02941B99-0A83-4FBF-91B9-CAF41E8CFA8A

Q44094350-0FC3514C-E6A0-47CA-BD74-BE686C3954FE

Q44094350-2267296C-7EB7-47BB-95D4-E150F176E18B

Q44094350-28281E91-04CC-43BA-A006-71E22E474BA0

Q44094350-2ACF9DF7-1159-4E5B-B8EE-7D6ACD563B23

Q44094350-3483C385-DBFB-4E59-906E-E20B166FCA24

Q44094350-35C92EFF-0889-4A77-A6F1-33F1F37F2A1E

Q44094350-3B32D9B8-1668-4CB6-971D-E03435320EF8

Q44094350-4437A794-D620-4153-BBF8-34D73C41B8DE

Q44094350-6640D222-D8BD-4D05-8DC0-8B93C43928C7

P304

Q44094350-F863545E-5CD5-43C1-9712-8BE554FDF3EB

P31

Q44094350-ED7013BB-25DD-46B5-8AFC-17A21C679F78

P356

Q44094350-CCFA9433-6B2F-4A5B-BB2C-FD6E9ACAF054

P433

Q44094350-70349DC8-5FA8-48FF-8795-5D39B38A6BC9

P478

Q44094350-C8FB58F1-87ED-4661-82DC-FB2052853A4F

P577

Q44094350-E917C90B-99AC-4978-86A6-2E0B4DDF42D4

P5875

Q44094350-D01F0E51-1076-4003-9A95-2151A76F2AEC

P698

Q44094350-57D475B5-9AE2-48F0-8BB6-9508B9E73750

P356

P1433

American Journal of Hematology

P1476

Outcome in hemoglobin SC disea ...... atologic, and genetic factors.

@en

P2093

Alan Hiti

http://www.w3.org/2001/XMLSchema#string

Cage Johnson

http://www.w3.org/2001/XMLSchema#string

Darleen R Powars

http://www.w3.org/2001/XMLSchema#string

Emily Ramicone

http://www.w3.org/2001/XMLSchema#string

Linda Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Trans-scleral diode laser photocoagulation in proliferative sickle cell retinopathy.

Beta-cluster haplotypes, alpha-gene status, and hematological data from SS, SC, and S-beta-thalassemia patients in southern California.

Palpable splenomegaly in children with haemoglobin SC disease: haematological and clinical manifestations.

Acute splenic complications in children with sickle cell-hemoglobin C disease.

Risk factors for proliferative sickle retinopathy.

Acute effects of increased intravascular volume and hypoxia on the pulmonary circulation: assessment with high-resolution CT.

Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Molecular and cellular pathogenesis of hemoglobin SC disease.

Chemical-shift-selective magnetic-resonance imaging of avascular necrosis of the femoral head.

Evolution of neovascularization in sickle cell retinopathy. A prospective fluorescein angiographic study.

P304

206-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.10140

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11266363

http://www.w3.org/2001/XMLSchema#string

P698

12111766

http://www.w3.org/2001/XMLSchema#string